Heartland Advisors Inc Albireo Pharma, Inc. Transaction History

Heartland Advisors Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$28.9 - $36.87 $2.02 Million - $2.58 Million	-70,000 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$31.56 - $42.16 $946,800 - $1.26 Million	-30,000 Reduced 30.0%	70,000 $2.63 Million
Q3 2020 Nov 12, 2020	SELL	$23.19 - $41.61 $1.16 Million - $2.08 Million	-50,000 Reduced 33.33%	100,000 $3.34 Million
Q1 2020 May 13, 2020	BUY	$11.67 - $27.23 $583,500 - $1.36 Million	50,000 Added 50.0%	150,000 $2.46 Million
Q4 2019 Feb 11, 2020	SELL	$16.92 - $28.96 $558,360 - $955,680	-33,000 Reduced 24.81%	100,000 $2.54 Million
Q2 2019 Aug 08, 2019	SELL	$30.67 - $37.86 $521,390 - $643,620	-17,000 Reduced 11.33%	133,000 $4.29 Million
Q1 2019 May 13, 2019	BUY	$22.22 - $32.21 $555,500 - $805,250	25,000 Added 20.0%	150,000 $4.83 Million
Q2 2018 Aug 02, 2018	BUY	$28.9 - $37.31 $973,265 - $1.26 Million	33,677 Added 36.88%	125,000 $4.44 Million
Q1 2018 May 10, 2018	BUY	$26.78 - $39.35 $2.45 Million - $3.59 Million	91,323 New	91,323 $2.97 Million

865

Ticker ALBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,612,500
Description
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...

Get notified when there are updates to the investment portfolio of Heartland Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Heartland Advisors Inc with notifications on news.